Comparative Effects of Dexmedetomidine and Propofol on US-Guided Radiofrequency Ablation of Hepatic Neoplasm Under Monitored Anesthesia Care: A Randomized Controlled Study

Kyoung-Woon Joung, Seong-Soo Choi, Dong-Min Jang, Yu-Gyeong Kong, Hwa-Mi Lee, Ji-Hoon Shim, Hyung-Jin Won, Yong-Moon Shin, Pyo-Nyun Kim, Myung-Hee Song, Kyoung-Woon Joung, Seong-Soo Choi, Dong-Min Jang, Yu-Gyeong Kong, Hwa-Mi Lee, Ji-Hoon Shim, Hyung-Jin Won, Yong-Moon Shin, Pyo-Nyun Kim, Myung-Hee Song

Abstract

Percutaneous radiofrequency ablation (RFA) is a useful and safe procedure for treating hepatic neoplasm. However, liver RFA causes severe pain, which thereby increases the demand for monitored anesthesia care (MAC). Here, we compared the efficacy and safety of propofol and dexmedetomidine, which are commonly administered during MAC when performing RFA to assess hepatic neoplasm.In this randomized controlled trial, 40 patients were randomly allocated to 2 groups for elective RFA. Patients received either dexmedetomidine (group D) or propofol (group P). Both groups received the continuous infusion of remifentanil for pain control. The primary outcomes were opioid consumption and differences in partial pressure of arterial carbon dioxide (PaCO2) between pre- and postprocedure RFA. In addition, hemodynamic parameters, patient satisfaction, and interventional radiologist satisfaction were determined.There were significant differences in opioid consumption (50.1 ± 16.8 ng/kg/min [group D] vs 71.2 ± 18.7 ng/kg/min [group P]; P = 0.001) and delta PaCO2 (10.4 ± 6.4 mm Hg vs 17.2 ± 9.2 mm Hg, respectively; P = 0.016). Moreover, respiratory rates were significantly different between groups during RFA (P < 0.001). However, blood pressure and heart rate did not significantly change during RFA. Neither patient nor interventional radiologist satisfaction was significantly different between groups.Dexmedetomidine provides better respiratory stability and reduces opioid consumption in comparison with propofol when administered under MAC when performing RFA for hepatic neoplasm.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Study design according to the CONSORT statement. MAC = monitored anesthesia care, RFA = radiofrequency ablation.
FIGURE 2
FIGURE 2
Differences in primary outcomes and Iowa Satisfaction with Anesthesia Scale. Data are expressed as the mean ± SD. PaCO2 = partial pressure of arterial carbon dioxide.
FIGURE 3
FIGURE 3
Changes in vital signs and BIS values during radiofrequency ablation. Data are expressed as the mean ± SD during radiofrequency ablation of hepatic neoplasm. ∗P < 0.05 and ∗∗∗P < 0.001 when compared between groups. †††P < 0.001 compared with preprocedure. BIS = bispectral index, Intra = intraprocedure, Post = postprocedure, Pre = preprocedure.

References

    1. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004; 15:463–470.
    1. Hwang JJ, Walther MM, Pautler SE, et al. Radio frequency ablation of small renal tumors: intermediate results. J Urol 2004; 171:1814–1818.
    1. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235–240.
    1. Mayo-Smith WW, Dupuy DE. Adrenal neoplasms: CT-guided radiofrequency ablation—preliminary results. Radiology 2004; 231:225–230.
    1. Rosenthal DI, Hornicek FJ, Torriani M, et al. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 2003; 229:171–175.
    1. Poon RT, Fan ST, Tsang FH, et al. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235:466–486.
    1. Carmi U, Kramer MR, Zemtzov D, et al. Propofol safety in bronchoscopy: prospective randomized trial using transcutaneous carbon dioxide tension monitoring. Respiration 2011; 82:515–521.
    1. Nelson DB, Barkun AN, Block KP, et al. Propofol use during gastrointestinal endoscopy. Gastrointest Endosc 2001; 53:876–879.
    1. Aantaa R, Jaakola ML, Kallio A, et al. A comparison of dexmedetomidine, and alpha 2-adrenoceptor agonist, and midazolam as i.m. premedication for minor gynaecological surgery. Br J Anaesth 1991; 67:402–409.
    1. Park IJ, Kim HC, Yu CS, et al. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 2008; 15:227–232.
    1. Dexter F, Candiotti KA. Multicenter assessment of the Iowa Satisfaction with Anesthesia Scale, an instrument that measures patient satisfaction with monitored anesthesia care. Anesth Analg 2011; 113:364–368.
    1. Ekstein M, Gavish D, Ezri T, et al. Monitored anaesthesia care in the elderly: guidelines and recommendations. Drugs Aging 2008; 25:477–500.
    1. Zhang Z, Xu F, Zhang C, et al. Activation of opioid mu receptors in caudal medullary raphe region inhibits the ventilatory response to hypercapnia in anesthetized rats. Anesthesiology 2007; 107:288–297.
    1. Glass PSA, Iselin-Chaves IA, Goodman D, et al. Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect. Anesthesiology 1999; 90:1556–1563.
    1. Smart JA, Pallett EJ, Duthie DJR. Breath interval as a measure of dynamic opioid effect. Br J Anaesth 2000; 84:735–738.
    1. Sarton E, Teppema L, Dahan A. Sex differences in morphine-induced ventilatory depression reside within the peripheral chemoreflex loop. Anesthesiology 1999; 90:1329–1338.
    1. Lynch RE, Hack RA. Methadone-induced rigid-chest syndrome after substantial overdose. Pediatrics 2010; 126:e232–e234.
    1. Ackerman WE, Phero JC, Theodore GT. Ineffective ventilation during conscious sedation due to chest wall rigidity after intravenous midazolam and fentanyl. Anesth Prog 1990; 37:46–48.
    1. Vaughn RL, Bennett CR. Fentanyl chest wall rigidity syndrome—a case report. Anesth Prog 1981; 28:50–51.
    1. Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93:409–417.
    1. Lumb A. Changes in the carbon dioxide partial pressure. Nunn's Applied Respiratory Physiology 7th ed.Toronto: Elsevier; 2010. 355–361.
    1. British Thoracic Society Bronchoscopy Guidelines Committee aSoSoCCoBTS. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 2001; 56 Suppl 1:i1–i21.
    1. Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol 2012; 62:118–133.
    1. Guarracino F, Lapolla F, Cariello C, et al. Target controlled infusion: TCI. Minerva Anestesiol 2005; 71:335–337.

Source: PubMed

3
Předplatit